Skip to main content
Top menu links
IMTM Portal
Support cancer research
User account menu
Intranet
Log in
Home
About us
Mission & vision
Management
Administration
Science advisory board
IMTM board
Certificates
Media & PR
REACTOR conference
Technologies & services
Core facilities
Equipment
Clinical trials
Technologies
Research
Data access committee
Data management plan
Research programs
Research projects
Laboratories and Research groups
Publications
Product pipeline
Mendel-Zirm lectures
Careers
Why the IMTM?
Bachelor
Master
Doctoral
Vacancies
Information for foreigners
Contact
General contacts
Staff
How to find us
E-shop
Header image
Breadcrumb
Home
Overcoming Resistance: Targeting Survivin-Driven Apoptotic Resistance Restores Irinotecan Sensitivity In TP53-Mutant Colorectal Cancer
Overcoming Resistance: Targeting Survivin-Driven Apoptotic Resistance Restores Irinotecan Sensitivity in TP53-Mutant Colorectal Cancer
DUMUT, D., Y. XU, D. VERELLI,
V. DAS
,
M. HAJDÚCH
,
J. DE SANCTIS
,
D. RADZIOCH
Overcoming Resistance: Targeting Survivin-Driven Apoptotic Resistance Restores Irinotecan Sensitivity in TP53-Mutant Colorectal Cancer. Cancers (Basel). 2026, 18(16), 2687, ISSN: 2072-6694, PMID:
42649998
,
PDF
.
